Conference abstractPublished 4 Jun 2018
Fabrication of Mg-4Y-2Nd-0.4Zr-0.25La microtubes for using as biodegradable stent in biomedical science
University of Tehran, Iran.
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Coronary heart disease (CHD) is the main cause of many deaths in our current world in which the coronary arteries are partially blocked or narrowed by the formation of plague. To solve this disease, angioplasty with stent placements has attracted a great deal of attention based on its lower levels of risk and acceptable efficacy. The traditional stents are made of 316L stainless steel and cobalt–chromium alloy which will indefinitely remain in the patients’ body and result in serious side effects like inflammation and thrombosis. In recent years temporary stents made from biodegradable metals especially Mg and its alloys have been considered as an alternative solution instead of the permanent ones, however, they face some profound limitations in their production process. In the current study, a new fabrication method including severe plastic deformation (SPD) process, direct extrusion, drilling, and microtube extrusion is proposed to produce Mg microtubes with improved mechanical properties. Based on previous studies, stents which are made from a material with an ultimate strength of >300 MPa and elongation of >15% can be a promising candidate for being used as biodegradable stents. By using the current method, large plastic strains are successively applied to the as-cast Mg at 400 ºC and consequently, the homogenous microstructure of the final microtube contains fine and ultrafine grains which causes high strength and high ductility Mg microtubes can overcome low formability of Mg alloys and facilitate the using of this promising material as biodegradable stents.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- BylineArticles whose byline prints “H Torabzadeh Kashi”